entX to decide on radiopharmaceutical, defence facility in 2024
Radiopharmaceutical developer entX Ltd is poised to make a decision to green light construction of a radiopharmaceutical production facility targeting cancer treatment with radioactive isotopes. The facility is supported by a $1.9 million Economic Recovery Fund (ERF) grant from the South Australian Government as well as a $2,915,000 Cooperative Research Centres Projects (CRC-P) grant announced…